Turn Therapeutics Inc. (TTRX) Stock: Financials, SEC Filings & Ownership
Market cap: $306.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 306.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 17 days
Price
The price chart — with earnings days, unusual moves, 8-Ks and insider trades marked — opens with a free account.
Our verdict
Five questions and why →Our read on this company
The verdict, the score behind it and the written thesis are in Analyst.
Try it free for 7 daysTiming
Today's price conditions
The verdict, the score behind it and the written thesis are in Analyst.
Try it free for 7 daysAnalyst note
Our written read on this company
The verdict, the score behind it and the written thesis are in Analyst.
Try it free for 7 daysDividends & buybacks
yield — · payout —No dividends or buybacks in the filed statements.
Performance
price return · vs. S&P 500 and the sector| Window | TTRX | vs. S&P 500 | vs. sector |
|---|---|---|---|
| 1 month | -22.5% | -21.5% | -28.0% |
| 3 months | +32.1% | +29.3% | +22.4% |
| 6 months | +190.0% | +183.5% | +165.6% |
| Year to date | +119.2% | +107.9% | +103.9% |
| 1 year | +145.9% | +132.1% | +123.1% |
Turn Therapeutics Inc. — questions
- What does Turn Therapeutics Inc. do?
- Turn Therapeutics Inc. operates in the Drug Manufacturers - General industry of the Healthcare sector.
- What is Turn Therapeutics Inc.'s market cap?
- $306.2M.
- Who owns Turn Therapeutics Inc. stock?
- 29 institutions reported Turn Therapeutics Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: SteelPeak Wealth (0.8%), Ieq Capital (0.8%), Ddfg (0.4%).
- When does Turn Therapeutics Inc. report earnings?
- Turn Therapeutics Inc.'s next earnings report is expected on 2026-11-12.
- What sector is Turn Therapeutics Inc. in?
- Turn Therapeutics Inc. is in the Healthcare sector, Drug Manufacturers - General industry.
- Who are Turn Therapeutics Inc.'s competitors?
- The nearest listed peers by market cap in Drug Manufacturers - General: Rezolute, Inc. (RZLT), NovaBridge Biosciences (NBP), GALECTIN THERAPEUTICS INC (GALT), Contineum Therapeutics, Inc. (CTNM), Benitec Biopharma Inc. (BNTC).
Every figure on this page comes from Turn Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
Source filings: FY2025 10-K · FY2024 10-K · balance sheet 10-Q for 2026-06-30
Peers and related: Rezolute, Inc. (RZLT) · NovaBridge Biosciences (NBP) · GALECTIN THERAPEUTICS INC (GALT) · Contineum Therapeutics, Inc. (CTNM) · Benitec Biopharma Inc. (BNTC) · All Drug Manufacturers - General companies
How these figures are read: methodology · EquiReason.